Abstract | BACKGROUND: METHODS: Forty-six pediatric patients (<18 years) presenting with acute anaphylaxis were assessed. Anaphylaxis severity was graded and serum anaphylaxis markers were measured acutely and in 36 children who returned for follow-up >4 weeks after their acute presentation. These markers were compared with pediatric laboratory reference sera. RESULTS: Severe anaphylaxis was experienced by 12/46 (26%) and mild-moderate anaphylaxis in 34/46 (74%) children. Platelet-activating factor acetylhydrolase (PAF-AH) activity was inversely associated with severe anaphylaxis: 9/12 children with severe anaphylaxis had reduced PAF-AH activity as compared with 14/34 with mild-moderate anaphylaxis (p < .05). Furthermore, 3/3 children who required intensive care had markedly reduced mean PAF-AH (nmol/ml/min) (13.73, 95%CI: 7.42-20.03) versus 20/23 who required ward/emergency department care (17.81, 95%CI: 16.80-18.83; p < .05). In children with anaphylaxis, PAF-AH during acute anaphylaxis was unchanged relative to the child's basal levels (mean, 17.26, 95%CI: 16.10-18.42 vs 17.50, 95%CI: 16.21-18.78, p = .63) and was lower than healthy pediatric controls (mean 19.21; 95%CI:18.21-20.21; p < .05). CONCLUSION:
|
Authors | Julia E M Upton, Jennifer A Hoang, Matilde Leon-Ponte, Yaron Finkelstein, Yue Jennifer Du, Khosrow Adeli, Thomas Eiwegger, Eyal Grunebaum, Peter Vadas |
Journal | Allergy
(Allergy)
Vol. 77
Issue 9
Pg. 2665-2676
(09 2022)
ISSN: 1398-9995 [Electronic] Denmark |
PMID | 35396721
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. |
Chemical References |
- Biomarkers
- Platelet Activating Factor
- 1-Alkyl-2-acetylglycerophosphocholine Esterase
|
Topics |
- 1-Alkyl-2-acetylglycerophosphocholine Esterase
- Adult
- Anaphylaxis
(diagnosis, etiology)
- Biomarkers
- Child
- Humans
- Platelet Activating Factor
(metabolism)
|